SCHEDULE 13G 0001319244 XXXXXXXX LIVE Common Stock, par value $0.00001 per share 03/06/2026 0001880438 AN2 Therapeutics, Inc. 037326105 1300 El Camino Real, Suite 100 Menlo Park CA 94025 Rule 13d-1(c) Integrated Core Strategies (US) LLC DE 0.00 2135044.00 0.00 2135044.00 2135044.00 N 6.0 OO Millennium Management LLC DE 0.00 2237102.00 0.00 2237102.00 2237102.00 N 6.3 OO Millennium Group Management LLC DE 0.00 2237102.00 0.00 2237102.00 2237102.00 N 6.3 OO Israel A. Englander X1 0.00 2237102.00 0.00 2237102.00 2237102.00 N 6.3 IN AN2 Therapeutics, Inc. 1300 El Camino Real, Suite 100, Menlo Park, California 94025 Integrated Core Strategies (US) LLC Millennium Management LLC Millennium Group Management LLC Israel A. Englander Integrated Core Strategies (US) LLC c/o Millennium Management LLC 399 Park Avenue New York, New York 10022 Millennium Management LLC 399 Park Avenue New York, New York 10022 Millennium Group Management LLC 399 Park Avenue New York, New York 10022 Israel A. Englander c/o Millennium Management LLC 399 Park Avenue New York, New York 10022 Integrated Core Strategies (US) LLC - Delaware Millennium Management LLC - Delaware Millennium Group Management LLC - Delaware Israel A. Englander - United States Y See response to Item 9 on each cover page. See response to Item 11 on each cover page. The percent of class was calculated based on 35,647,635 shares of Common Stock outstanding, which is the sum of (i) 27,402,024 shares of Common Stock outstanding as of November 3, 2025, as reported in the issuer's Form 10-Q filed with the SEC on November 12, 2025, and (ii) 8,245,611 shares of Common Stock issued in connection with a private placement that closed on or about March 10, 2026, as reported in the issuer's Form 8-K filed with the SEC on March 10, 2026. See response to Item 5 on each cover page. See response to Item 6 on each cover page. See response to Item 7 on each cover page. See response to Item 8 on each cover page. The securities disclosed herein as potentially beneficially owned by Millennium Management LLC, Millennium Group Management LLC and Mr. Englander are held by entities subject to voting control and investment discretion by Millennium Management LLC and/or other investment managers that may be controlled by Millennium Group Management LLC (the managing member of Millennium Management LLC) and Mr. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). The foregoing should not be construed in and of itself as an admission by Millennium Management LLC, Millennium Group Management LLC or Mr. Englander as to beneficial ownership of the securities held by such entities. Y Y Y N See Exhibit I Y N By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11. Exhibit I: Joint Filing Agreement, dated as of March 12, 2026, by and among Integrated Core Strategies (US) LLC, Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander. Integrated Core Strategies (US) LLC /s/ Gil Raviv 03/12/2026 Millennium Management LLC /s/ Gil Raviv 03/12/2026 Millennium Group Management LLC /s/ Gil Raviv 03/12/2026 Israel A. Englander /s/ Israel A. Englander 03/12/2026 ** INTEGRATED CORE STRATEGIES (US) LLC By: Integrated Holding Group LP, its Managing Member By: Millennium Management LLC, its General Partner